Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Upendra A. Argikar, Jennifer L. Dumouchel, Christine E. Dunne & Andrea J. Bushee. (2017) Ocular non-P450 oxidative, reductive, hydrolytic, and conjugative drug metabolizing enzymes. Drug Metabolism Reviews 49:3, pages 372-394.
Read now
Read now
Charu Sharma, Nihar R Biswas, Shreesh Ojha & Thirumurthy Velpandian. (2016) Comprehensive evaluation of formulation factors for ocular penetration of fluoroquinolones in rabbits using cassette dosing technique. Drug Design, Development and Therapy 10, pages 811-823.
Read now
Read now
Articles from other publishers (29)
Murat Akkurt Arslan, Françoise Brignole-Baudouin, Solenne Chardonnet, Cédric Pionneau, Frédéric Blond, Christophe Baudouin & Karima Kessal. (2023) Profiling tear film enzymes reveals major metabolic pathways involved in the homeostasis of the ocular surface. Scientific Reports 13:1.
Crossref
Crossref
Divyesh H. Shastri, Ana Catarina Silva & Hugo Almeida. (2023) Ocular Delivery of Therapeutic Proteins: A Review. Pharmaceutics 15:1, pages 205.
Crossref
Crossref
Anam Hammid, John K. Fallon, Toni Lassila, Paula Vieiro, Anusha Balla, Francisco Gonzalez, Arto Urtti, Philip C. Smith, Ari Tolonen & Paavo Honkakoski. (2022) Activity and Expression of Carboxylesterases and Arylacetamide Deacetylase in Human Ocular Tissues. Drug Metabolism and Disposition 50:12, pages 1483-1492.
Crossref
Crossref
Sara Aly Attia & J. Andrew MacKay. (2022) Protein and polypeptide mediated delivery to the eye. Advanced Drug Delivery Reviews 188, pages 114441.
Crossref
Crossref
Santoshi Naik, Prashansha Mullick, Sadhana P Mutalik, Aswathi R Hegde, Shaila Angela Lewis, Krishnamurthy Bhat, Bola Sadashiva Satish Rao & Srinivas Mutalik. (2022) Full Factorial Design for Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Timolol Maleate in Surfactant-Based Elastic Nano-Vesicular Systems. Journal of Chromatographic Science 60:6, pages 584-594.
Crossref
Crossref
Eva M. del Amo, Anam Hammid, Melanie Tausch, Elisa Toropainen, Amir Sadeghi, Annika Valtari, Jooseppi Puranen, Mika Reinisalo, Marika Ruponen, Arto Urtti, Achim Sauer & Paavo Honkakoski. (2022) Ocular metabolism and distribution of drugs in the rabbit eye: Quantitative assessment after intracameral and intravitreal administrations. International Journal of Pharmaceutics 613, pages 121361.
Crossref
Crossref
James E. Chastain. 2022. Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics. Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics
179
219
.
Dylan E. Parsons, Soo Hyeon Lee, Young Joo Sun, Gabriel Velez, Alexander G. Bassuk, Mark Smith & Vinit B. Mahajan. (2021) Peptidomimetics Therapeutics for Retinal Disease. Biomolecules 11:3, pages 339.
Crossref
Crossref
Gloria Cimaglia, Marcela Votruba, James E. Morgan, Helder André & Pete A. Williams. (2020) Potential Therapeutic Benefit of NAD+ Supplementation for Glaucoma and Age-Related Macular Degeneration. Nutrients 12:9, pages 2871.
Crossref
Crossref
Santoshi Naik, Abhijeet Pandey, Shaila A. Lewis, Bola Sadashiva Satish Rao & Srinivas Mutalik. (2020) Neuroprotection: A versatile approach to combat glaucoma. European Journal of Pharmacology 881, pages 173208.
Crossref
Crossref
Zufika Qamar, Farheen Fatima Qizilbash, Mohammad Kashif Iqubal, Asgar Ali, Jasjeet Kaur Narang, Javed Ali & Sanjula Baboota. (2020) Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective. Recent Patents on Drug Delivery & Formulation 13:4, pages 246-254.
Crossref
Crossref
Yosra Agban, Sachin S. Thakur, Odunayo O. Mugisho & Ilva D. Rupenthal. (2019) Depot formulations to sustain periocular drug delivery to the posterior eye segment. Drug Discovery Today 24:8, pages 1458-1469.
Crossref
Crossref
Upendra A. Argikar, Jennifer L. Dumouchel, Valerie M. Kramlinger, Amanda L. Cirello, Mithat Gunduz, Christine E. Dunne & Bindi Sohal. (2017) Do We Need to Study Metabolism and Distribution in the Eye: Why, When, and Are We There Yet?. Journal of Pharmaceutical Sciences 106:9, pages 2276-2281.
Crossref
Crossref
David Waite, Yujing Wang, David Jones, Alan Stitt & Thakur Raghu Raj Singh. (2017) Posterior drug delivery via periocular route: challenges and opportunities. Therapeutic Delivery 8:8, pages 685-699.
Crossref
Crossref
M. Ferrell Ramos, M. Attar, M.E. Stern, J.A. Brassard, A.S. Kim, S. Matsumoto & C. Vangyi. 2017. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
757
811
.
Masaaki KurataIkuyo AtsumiYoshinori YamagiwaHideyuki Sakaki. (2016) Ocular instillation toxicity study: current status and points to consider on study design and evaluation. Fundamental Toxicological Sciences 3:5, pages 217-232.
Crossref
Crossref
Jose Cunha-Vaz, Francisco Batel Marques, Rosa Fernandes, Carlos Alves & Thirumurthy Velpandian. 2016. Pharmacology of Ocular Therapeutics. Pharmacology of Ocular Therapeutics
37
63
.
Chandrasekar Durairaj. 2017. Pharmacologic Therapy of Ocular Disease. Pharmacologic Therapy of Ocular Disease
31
55
.
Ivan Pepić, Jasmina Lovrić, Biserka Cetina-Čižmek, Stephan Reichl & Jelena Filipović-Grčić. (2014) Toward the practical implementation of eye-related bioavailability prediction models. Drug Discovery Today 19:1, pages 31-44.
Crossref
Crossref
Mayssa Attar, Jacqueline A. Brassard, Andrea S. Kim, Steven Matsumoto, Meg Ramos & Chang Vangyi. 2013. A Comprehensive Guide to Toxicology in Preclinical Drug Development. A Comprehensive Guide to Toxicology in Preclinical Drug Development
567
617
.
Poonam R. Velagaleti & Michael H. Buonarati. 2014. Ocular Pharmacology and Toxicology. Ocular Pharmacology and Toxicology
33
52
.
Yadollah Omidi, Jaleh Barar & Hossein Hamzeiy. 2012. Nanotechnology in Health Care. Nanotechnology in Health Care
43
106
.
Christian KöllnStephan Reichl. (2012) mRNA Expression of Metabolic Enzymes in Human Cornea, Corneal Cell Lines, and Hemicornea Constructs. Journal of Ocular Pharmacology and Therapeutics 28:3, pages 271-277.
Crossref
Crossref
Marjo Volotinen, Jukka Hakkola, Olavi Pelkonen, Heikki Vapaatalo & Jukka Mäenpää. (2011) Metabolism of Ophthalmic Timolol: New Aspects of an Old Drug. Basic & Clinical Pharmacology & Toxicology 108:5, pages 297-303.
Crossref
Crossref
Ketan Hippalgaonkar, Ramesh Srirangam, Bharathi Avula, Ikhlas A. Khan & Soumyajit Majumdar. (2010) Interaction between Topically and Systemically Coadministered P-Glycoprotein Substrates/Inhibitors: Effect on Vitreal Kinetics. Drug Metabolism and Disposition 38:10, pages 1790-1797.
Crossref
Crossref
Joel W. Proksch & Keith W. Ward. (2008) Cassette Dosing Pharmacokinetic Studies for Evaluation of Ophthalmic Drugs for Posterior Ocular Diseases. Journal of Pharmaceutical Sciences 97:8, pages 3411-3421.
Crossref
Crossref
Yoshihisa Shirasaki. (2008) Molecular Design for Enhancement of Ocular Penetration. Journal of Pharmaceutical Sciences 97:7, pages 2462-2496.
Crossref
Crossref
Moorthy S. S. Palanki, Hideo Akiyama, Peter Campochiaro, Jianguo Cao, Chun P. Chow, Luis Dellamary, John Doukas, Richard Fine, Colleen Gritzen, John D. Hood, Steven Hu, Shu Kachi, Xinshan Kang, Boris Klebansky, Ahmed Kousba, Dan Lohse, Chi Ching Mak, Michael Martin, Andrew McPherson, Ved P. Pathak, Joel Renick, Richard Soll, Naoyasu Umeda, Shiyin Yee, Katsutoshi Yokoi, Binqi Zeng, Hong Zhu & Glenn Noronha. (2008) Development of Prodrug 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Benzoate (TG100801): A Topically Administered Therapeutic Candidate in Clinical Trials for the Treatment of Age-Related Macular Degeneration. Journal of Medicinal Chemistry 51:6, pages 1546-1559.
Crossref
Crossref
Eugen Barbu, Liliana Verestiuc, Thomas G. Nevell & John Tsibouklis. (2006) Polymeric materials for ophthalmic drug delivery: trends and perspectives. Journal of Materials Chemistry 16:34, pages 3439.
Crossref
Crossref